Cite

HARVARD Citation

    Satouchi, M. et al. (2020). First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset. Cancer science. 111 (12), pp. 4480-4489. [Online]. 
  
Back to record